DBALX
Price
$13.70
Change
+$0.03 (+0.22%)
Updated
Oct 17 closing price
Net Assets
269.04M
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.37B
Interact to see
Advertisement

DBALX vs RLBEX

Header iconDBALX vs RLBEX Comparison
Open Charts DBALX vs RLBEXBanner chart's image
Davenport Balanced Income
Price$13.70
Change+$0.03 (+0.22%)
VolumeN/A
Net Assets269.04M
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.37B
DBALX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
DBALX vs. RLBEX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBALX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 265B vs. DBALX (269M). DBALX pays higher dividends than RLBEX: DBALX (2.53) vs RLBEX (1.74). DBALX was incepted earlier than RLBEX: DBALX (10 years) vs RLBEX (23 years). DBALX (0.93) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. DBALX (25.00). RLBEX has a lower initial minimum investment than DBALX: RLBEX (250) vs DBALX (5000). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. DBALX (2.84). RLBEX return over 5 years is better than : 42.04 vs. DBALX (30.56).
DBALXRLBEXDBALX / RLBEX
Total Expense Ratio0.930.59158%
Annual Report Gross Expense Ratio0.930.59158%
Fund Existence10 years23 years-
Gain YTD7.61914.63152%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets269M265B0%
Annual Yield % from dividends2.531.74146%
Returns for 1 year2.848.7033%
Returns for 3 years26.6250.5253%
Returns for 5 years30.5642.0473%
Returns for 10 yearsN/A77.69-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ELAN21.420.90
+4.39%
Elanco Animal Health
UK1.040.01
+0.97%
Ucommune International Ltd
XBIT2.49N/A
N/A
XBiotech
WLYB36.95-0.41
-1.10%
John Wiley & Sons
JBIO9.37-0.41
-4.24%
Jade Biosciences Inc